MTP Session IX: CLL | Looking Ahead When You Plan First-Line Therapy

Session Chair: Mary Ann Anderson, MBBS, FRACP, FRCPA, PhD

• Case: Why I Started This Patient on a BTKi | Joanna M. Rhodes, MD, MSCE | Rutgers Cancer Institute, New Brunswick, New Jersey, USA

• Case: Why I Started This Patient on VenG | Javier Pinilla-Ibarz, MD, PhD | H. Lee Moffitt Cancer Center, Tampa, Florida, USA

• Case: Why I Started This Patient on BTKi + BCL2 +/- O | Paolo Ghia, MD, PhD | Università Vita-Salute San Raffaele, Milano, Italy